The Pennant Group (PNTG) Oppenheimer 36th Annual Healthcare MedTech & Services Conference summary

Business performance and recent acquisitions

• Ended Q4 with strong momentum, highlighted by the largest acquisitions in company history, including assets from UnitedHealth Group and Amedisys.

• Expansion has created significant opportunities for leadership development and internal growth.

• Early signs from Southeast expansion are positive, but integration and transition remain a key focus.

• Home Health, Hospice, and Senior Living segments show momentum, with further optimization and efficiency gains targeted.

Financial guidance and integration strategy

• Guidance incorporates conservatism due to the complexity of the Amedisys/UnitedHealth Group transition, including system, brand, and employee changes.

• Productivity impacts and third-party collections during transition are factored into projections.

• Integration is proceeding in five waves, expected to complete by October, with positive early results and strong employee retention.

• Full optimization of acquired businesses is targeted within a 12-24 month window.

Margin targets and segment outlook

• Targeting a 10.5% annualized margin by end of 2026 for new assets, with a long-term goal of 18% margin in line with existing operations.

• Home Health and Hospice segment expected to reach 16% EBITDA margin; Senior Living aiming for 11% annualized margin.